Stock comparison
ImmunityBio
IBRX$7.8BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$106.55BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
IBRX 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
IBRX0wins
7winsSANOFICONR.NS
31F
B78
45D
A89
53D
B83
52D
B77
2F
A91
53D
A86
55D
A85
Side-by-side metrics
| Metric | IBRX | SANOFICONR.NS |
|---|---|---|
| Market cap | $7.8B | $106.55B Winner |
| P/E (TTM) | Winner: - | 44.2x |
| EV/EBIT | Winner: - | 31.8x |
| ROIC (TTM) | -44.51% | 59.15% Winner |
| Gross margin | Winner: 93.79% | 68.13% |
| Net margin | -6.06% | 27.35% Winner |
| Revenue CAGR 5y | Winner: 2.32% | 27.01% |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | Winner: - | 0.1x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IBRX leads on
- EV/EBIT-vs 31.8x+194%
- P/E (TTM)-vs 44.2x+120%
- Debt / Equity-vs 0.1x+105%
- Revenue CAGR 5y2.32%vs 27.01%+88%
SANOFICONR.NS leads on
- ROIC (TTM)59.15%vs -44.51%+175%
- Net margin27.35%vs -6.06%+105%
- Market cap$106.55Bvs $7.8B+93%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.